Hepatitis B Surface Antigen S Gene is an Effective Carrier Molecule for Developing GnRH DNA Immunocastration Vaccine in Mice.

about

Hepatitis B Surface Antigen S Gene is an Effective Carrier Molecule for Developing GnRH DNA Immunocastration Vaccine in Mice.

Item

http://www.wikidata.org/entity/Q47873692

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Hepatitis B Surface Antigen S ...... unocastration Vaccine in Mice.

@en

Hepatitis B Surface Antigen S ...... unocastration Vaccine in Mice.

@nl

type

Item

label

Hepatitis B Surface Antigen S ...... unocastration Vaccine in Mice.

@en

Hepatitis B Surface Antigen S ...... unocastration Vaccine in Mice.

@nl

prefLabel

Hepatitis B Surface Antigen S ...... unocastration Vaccine in Mice.

@en

Hepatitis B Surface Antigen S ...... unocastration Vaccine in Mice.

@nl

P1476

Hepatitis B Surface Antigen S ...... unocastration Vaccine in Mice.

@en

P2093

B Tesema

http://www.w3.org/2001/XMLSchema#string

G Q Liu

http://www.w3.org/2001/XMLSchema#string

J Y Zhao

http://www.w3.org/2001/XMLSchema#string

N Ijaz

http://www.w3.org/2001/XMLSchema#string

W J Ye

http://www.w3.org/2001/XMLSchema#string

X P Jiang

http://www.w3.org/2001/XMLSchema#string

Y G Han

http://www.w3.org/2001/XMLSchema#string

P2860

Contraceptive vaccines for wildlife: a review

Development and evaluation of a novel DNA vaccine expressing inhibin alpha (1-32) fragment for improving the fertility in rats and sheep

Polymeric Materials for Gene Delivery and DNA Vaccination

CD40L-adjuvanted DNA/modified vaccinia virus Ankara simian immunodeficiency virus SIV239 vaccine enhances SIV-specific humoral and cellular immunity and improves protection against a heterologous SIVE660 mucosal challenge

Long-term fertility control in female cats with GonaCon™, a GnRH immunocontraceptive.

Assuring the quality, safety, and efficacy of DNA vaccines.

DNA vaccines in veterinary use.

Immunological response to parenteral vaccination with recombinant hepatitis B virus surface antigen virus-like particles expressing Helicobacter pylori KatA epitopes in a murine H. pylori challenge model.

Clinical potential of electroporation for gene therapy and DNA vaccine delivery.

As a genetic adjuvant, CTA improves the immunogenicity of DNA vaccines in an ADP-ribosyltransferase activity- and IL-6-dependent manner.

P304

445-450

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/RDA.12692

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27157596

http://www.w3.org/2001/XMLSchema#string